Receipt of guideline-concordant treatment is associated with improved survival among patients with endometrial cancer, and racial and ethnic disparities in receipt of guideline-concordant care are well established. However, the extent to which guideline-concordant treatment disparities contribute to racial and et...
Ashley S. Felix, Simran A. Kanal, Caitlin E. Meade et al.· Cancer Epidemiology, Biomark...· 0 citations
Background: Guideline-concordant treatment (GCT) is a key indicator of cancer care quality, yet most studies rely on cancer registry data, which incompletely capture treatment adequacy and vary in population composition. As a result, estimates of racial and ethnic disparities in GCT may differ depending on treatment me...
Ashley S. Felix, Caitlin E. Meade, Simran A. Kanal et al.· Cancer Epidemiology, Biomark...· 0 citations
OBJECTIVES
Clinical trials are essential to therapeutic advancement, yet access to trials in ovarian cancer may not be equitably distributed. This study evaluated associations between community-level social vulnerability and county-level availability of interventional ovarian cancer clinical trials in the United States...
Reed M. O'Connor, Jennifer A. Sinnott, Caitlin E. Meade et al.· Gynecologic Oncology· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.